MPT: At Long Last, Inflammatory Hypothesis Confirmed in CVD by CANTOS

ACC Conference Reporter

ESC 2017 | BARCELONA — Long-awaited evidence that targeting an inflammatory pathway can reduce heart attacks and stroke independent of lipids is now in hand -- canakinumab (Ilaris) reduced events by 15% compared with placebo. Read More >>>

Keywords: ESC2017, ESC Congress


< Back to Listings